Opinion | ‘We Should Be Really Concerned’: What We Heard This Week
“If we start seeing lots of cases outside of agricultural workers, we should be really concerned.” — James Lawler, MD, MPH, of the University of
“If we start seeing lots of cases outside of agricultural workers, we should be really concerned.” — James Lawler, MD, MPH, of the University of
Kon is a cardiothoracic surgeon with expertise in heart and lung transplant, and the founder and CEO of ProCure On-Demand. I have always been a
Ron Harman King is CEO of Vanguard Communications, a healthcare marketing and practice management consulting firm, and author of “The Totally Wired Doctor: Social Media,
Early in 2024, we reported on the FDA’s call for new boxed warnings on the labeling of all approved chimeric antigen receptor (CAR) T-cell therapies
Human MxA protein suppresses mammalian H5N1 virus replication, but emerging mutations may enable partial evasion, raising concerns for human transmission.
Loss of the Y chromosome (LOY) in men, a dynamic mutation linked to aging, impairs immune function and increases risks of cancer, Alzheimer’s, and cardiovascular
Vaccination drastically reduces avian influenza outbreaks in ducks, but enhanced passive surveillance is crucial for timely and effective detection of the virus.
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes